Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Amlodipine 10 mg tablet

Canada Type II Ongoing · initiated 2025-09-26

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

SV Labs Prescott Corporation

US Class II Ongoing · initiated 2025-09-25

cGMP deviations: the firm released and distributed product which failed total aerobic microbial count testing.

No7 Restore & Renew Face & Neck Multi Action Day Cream SPF 30

Canada Type III Ongoing · initiated 2025-09-25

Other. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Con…

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-09-24

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

Zydus Pharmaceuticals (USA) Inc

US Class II Ongoing · initiated 2025-09-24

Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2025-09-23

Product Mix-up

Park Avenue Compounding

US Class II Ongoing · initiated 2025-09-23

CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.

Jamp-Senna 8.6 mg table

Canada Type II Ongoing · initiated 2025-09-23

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

MAG Trio capsules

Canada Type III Ongoing · initiated 2025-09-23

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

RC Outsourcing, LLC

US Class II Terminated · initiated 2025-09-22

Lack of assurance of sterility.

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-09-19

Failed Dissolution Specifications

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-09-19

Failed Dissolution Specifications

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-09-19

Failed Dissolution Specifications

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2025-09-19

Failed Dissolution Specifications

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2025-09-17

CGMP Deviations: Market complaints received for gritty texture (grainy)

Park Avenue Compounding

US Class II Ongoing · initiated 2025-09-17

CGMP Deviations

ACCORD HEALTHCARE, INC.

US Class II Ongoing · initiated 2025-09-16

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification ra…

IntegraDose Compounding Services LLC

US Class I Ongoing · initiated 2025-09-16

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

Amerisource Health Services LLC

US Class II Ongoing · initiated 2025-09-15

Failed Dissolution Specifications.

Graviti Pharmaceuticals Private Limited

US Class II Ongoing · initiated 2025-09-15

Failed Tablet/Capsule Specifications

Private Label Skin Care Inc.

US Class II Ongoing · initiated 2025-09-12

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide…

Private Label Skin Care Inc.

US Class II Ongoing · initiated 2025-09-12

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide…

Private Label Skin Care Inc.

US Class II Ongoing · initiated 2025-09-12

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide…

Private Label Skin Care Inc.

US Class II Ongoing · initiated 2025-09-12

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide…

Private Label Skin Care Inc.

US Class II Ongoing · initiated 2025-09-12

Chemical Contamination: This recall has been initiated due to elevated levels of benzene that was discovered during post consume awareness with benzoyl peroxide…